MedPath

To understand how individuals with ringing sensation in the ears can shift attention away from the ringing in the ear, effortful listening abilities and measurement of fatigue.

Phase 2
Conditions
Health Condition 1: H838- Other specified diseases of innerear
Registration Number
CTRI/2023/01/048681
Lead Sponsor
Sanjana M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Phase 1

- Participants who are native Kannada speakers, or non-native Kannada speakers with self-reported good to excellent language skills

- Individuals with tinnitus (present in one or both ears), hearing loss (with and without tinnitus)

- Individuals with hearing loss whose hearing acuity ranges from mild to severe

Phase 2 (Group 1)

- Participants who are native Kannada speakers, or non-native Kannada speakers with self-reported good to excellent language skills

- Participants with hearing sensitivity <40 dB HL at all frequencies 0.25 to 8kHz

- Phase 2 (Group 2)

- Participants with hearing sensitivity <40 dB HL at all frequencies 0.25 to 8kHz

- Individuals who are age and gender-matched to Group 1

- Montreal Cognitive Assessment (MoCA) scores greater than 26 (out of 30)

- Participants should have normal middle ear functioning which will be confirmed using Interacoustics AT235H middle ear analyzer.

- Participants with normal outer hair cell functioning.

Exclusion Criteria

Phase 1

- Any diagnosed neurological or psychological impairments.

Phase 2

- Participants with hearing sensitivity <40 dB HL at all frequencies 0.25 to 8kHz

- Individuals who are age and gender-matched to Group 1

- Montreal Cognitive Assessment (MoCA) scores greater than 26 (out of 30)

- Participants should have normal middle ear functioning which will be confirmed using Interacoustics AT235H middle ear analyzer.

- Participants with normal outer hair cell functioning.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath